HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of hydroxyethyl starch conjugated deferoxamine on myocardial functional recovery following coronary occlusion and reperfusion in dogs.

Abstract
The effect of hydroxyethyl starch-conjugated deferoxamine (HES-DFO) on the recovery of regional myocardial function after 15 min of coronary artery occlusion followed by 3 h of reperfusion of the left anterior descending coronary artery (stunned myocardium) was investigated in anesthetized dogs. Regional myocardial blood flow was measured by radioactive microspheres and regional myocardial segment shortening (%SS) by sonomicrometry. HES-DFO (equivalent of 50 mg/kg DFO), iron saturated HES-DFO (HES-FO), deferoxamine (DFO, 50 mg/kg), or saline were administered by intravenous infusion starting 30 min before occlusion and throughout occlusion. Ischemic bed size and collateral blood flow were similar in all four groups. HES-DFO significantly improved %SS in the ischemic-reperfused region during reperfusion; however, HES-FO and DFO had no effect on %SS as compared to the saline-treated group. HES-DFO and HES-FO had no effect on hemodynamics; however, DFO produced a marked reduction in systemic blood pressure. Since HES-FO had no effect on the recovery of %SS, the beneficial effect of HES-DFO is thought to be due to its iron chelating characteristics. Plasma concentrations of HES-DFO not only reached a higher peak level but also had a longer half life (3 h) than that of regular DFO (20 min). Thus, high-molecular-weight HES-DFO is effective in enhancing the recovery of regional wall motion in stunned myocardium. The reason for the lack of efficacy of DFO compared to HES-DFO at this high dose may be related to the formation of a toxic deferoxamine free radical species.
AuthorsM Maruyama, G M Pieper, B Kalyanaraman, P E Hallaway, B E Hedlund, G J Gross
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 17 Issue 1 Pg. 166-75 (Jan 1991) ISSN: 0160-2446 [Print] United States
PMID1708051 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Hydroxyethyl Starch Derivatives
  • hydroxyethyl starch-deferoxamine conjugate
  • Deoxyribose
  • Deferoxamine
Topics
  • Animals
  • Coronary Circulation (drug effects, physiology)
  • Deferoxamine (administration & dosage, metabolism, pharmacology)
  • Deoxyribose (metabolism)
  • Dogs
  • Dose-Response Relationship, Drug
  • Electron Spin Resonance Spectroscopy (methods)
  • Female
  • Heart (drug effects, physiology)
  • Hemodynamics (drug effects)
  • Hydroxyethyl Starch Derivatives (pharmacology)
  • Male
  • Reperfusion Injury (drug therapy, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: